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Abstract. Objective: To investigate the effect of the X-linked 
immunodefi ciency (Xid) B cell defect on the response to the 
cockroach allergen in mice. 
Methods: Two cockroach allergen immunization and chal-
lenge protocols were employed to sensitize CBA/J wild-type 
and CBA/CaHN-btk(-/-)xid/J (Xid) mice. Blood and tissue 
samples were collected 24 and 48 hrs after the last intrat-
racheal antigen challenge and were analyzed for several 
parameters of allergic infl ammation.
Results: Nearly equivalent amounts of serum IgE were de-
tected in Xid and CBA/J mice after short-term antigen chal-
lenge despite the B cell defi ciency in Xid mice. A decreased 
concentration of IgE was detected in CBA/J mice after re-
peated allergen challenges but not in the Xid mice. Correlat-
ing with the discrepancy in serum IgE levels, higher levels of 
IL-13, IL-5, IL-10 and CCL5 were measured in whole lung 
homogenates from allergen-challenged Xid mice compared 
to CBA/J mice. In addition, draining lymph node cells from 
Xid mice expressed elevated levels of IL-4, IL-5, IL-10 and 
IFNg mRNA compared to cells from CBA/J mice after in 
vitro culture with cockroach antigen. An increase in lung 
infl ammation, interstitial eosinophilia and mucus production 
was also observed in allergen-challenged Xid mice. CD95L 
expression increased on B-1a cells following allergen chal-
lenge, which was accompanied by an increase in lung CD4+ 
Th cell apoptosis in wild-type CBA/J mice. In contrast, Xid 
mice did not have an increase in CD4+ T cell apoptosis fol-
lowing allergen challenge. 
Conclusions: These data suggest a regulatory role for B-1a 
cells in reducing cytokine production, pulmonary infl amma-
tion, and CD4+ T cell survival during cockroach allergen-in-
duced airway infl ammation. 
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Introduction
Asthma is a chronic disease of the lung caused by exacerbat-
ed immune response toward environmental allergens. Much 
previous investigation has established that CD4+ T helper 
lymphocytes play a pivotal role in the establishment and 
maintenance of asthma. [1–3] These T helper cells produce 
Th2-associated cytokines including: IL-4, IL-5 and IL-13, 
which have pluripotent roles in promoting allergic reactions. 
[4, 5] In the setting of asthma, IL-4 stimulates differentiation 
of Th2 cells and proliferation of B cells, drives antigen-spe-
cifi c antibody production by B cells toward IgG1 and IgE iso-
types, and inhibits production of the Th1-associated cytokine 
IL-12. [6–10] IgE binds to basophils and mast cells through 
surface Fce receptors, which when stimulated by antigen, 
cause the release of basophilic granules containing hista-
mines and leukotrienes, that in turn stimulate the contraction 
of airway smooth muscle. [11–13] In asthma, IL-5 stimulates 
the production and maturation of eosinophils, which travel to 
the airways and release granular material, leading to mucus 
production and eventual airway remodeling in severe cases. 
[14] IL-13 shares some common activities with IL-4 through 
a common receptor, but has some non-redundant roles in-
cluding being a major contributor to fi broblast stimulation 
and increased pulmonary fi brosis. [15–17] In addition to the 
Th2 cytokines, CD4+ T cells are a major source of chemok-
ines that direct traffi cking and activation of lymphocytes and Correspondence to: N. W. Lukacs
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leukocytes into infl amed airways. [5, 18] Thus, the CD4+ Th 
cell is an attractive target for understanding and regulating 
asthmatic responses.
A major, naturally occurring mechanism of CD4+ T cell 
regulation during infl ammation is activation-induced cell 
death or apoptosis. Apoptosis is an important mechanism in 
the regulation of lung infl ammation in asthma as indicated 
by an increase in chronicity when apoptosis is reduced. [19] 
Although histological analysis has not yet established an 
increase in total CD4+ T cell apoptosis in asthmatic patients, 
careful examination has revealed that T cells expressing 
IFN-g are more apoptotic in asthmatics than in healthy sub-
jects. [20] Although T cell apoptosis has been identifi ed in 
asthmatics, the effector cells involved and the mechanisms 
employed to induce death are not completely understood.
It has recently been demonstrated that B cells, especially 
the CD5+/CD19+ B-1a cell subset, increase expression of 
surface Fas ligand (CD95L) in response to the Th2-inducing 
antigens of schistosome eggs. [21, 22] The B-1a cell subset 
is present in the pleural and peritoneal cavities, as well as the 
spleen but is not commonly found in lymph nodes. [23, 24] B-
1a cells tend to recognize T-independent antigens such as lipids 
and carbohydrate moieties on glycoproteins and glycolipids, 
which are found in most common allergens. [25] Additionally, 
peritoneal B-1a cells have been shown to produce IL-10 upon 
antigenic stimulation. [26–28] These properties suggested a 
potential role for B-1a cells as a regulatory cell population at 
mucosal surfaces including the airways of the lung.
To test the hypothesis that B-1a cells contributed to the 
regulation of CD4+ T cells in asthma, cockroach allergen-
induced (CRAg) models of asthma were performed in B-1a 
cell defi cient, CBA/CaHN(btk -/-)Xid/J mice and compared 
to wild-type CBA/J mice. Increased serum IgE levels and 
airway infl ammation were observed in allergen-challenged 
Xid mice. Lung cytokine levels were elevated in Xid mice and 
antigen-stimulated lymph node cells from Xid mice produced 
more Th1 and Th2 cytokines compared to wild-type mice. De-
creased T cell death was also observed in allergen-challenged 
Xid mice. Thus, the B cell population missing from Xid mice 
appeared to play an important role in regulation of allergen-
sensitized T cells and control of airway infl ammation.
Material and methods
Mice and Reagents
Age-matched, female CBA/J and CBA/CaHN-btk(-/-)xid/J (Xid) mice 
were purchased from Jackson Labs (Bar Harbor, ME) and housed 
under pathogen free conditions in the University Laboratory Animal 
Management facility at the University of Michigan Medical School. 
Mice were fed and drank ad libitum and were tested (negative) for the 
presence of many standard mouse pathogens. To ensure mutant status 
of mice, peritoneal lavage cells and collagenase dispersed lung cells 
were stained with anti-mouse CD19-FITC and anti-mouse CD5-PE an-
tibodies (Pharmingen, San Diego, CA) and analyzed by two-color fl ow 
cytometry. All Xid mice completely lacked CD5+/CD19+ double posi-
tive B cells and had an approximately 50 % reduction in CD5-/CD19+ 
B cells. [29] There were no detectable differences in growth, behavior or 
health between the two groups of mice throughout the course of the ex-
periments. Skin test-grade cockroach antigen (CRAg) extracts were pur-
chased from Hollister Stier (Spokane, WA) and tested negative for bac-
terial lipopolysaccharides by limulus amoebocyte assay. Antibodies for 
fl ow cytometry and other reagents were purchased from BD/Pharmingen 
(San Diego, CA) and Sigma/Aldrich (St. Louis, MO).
Cockroach Allergen Sensitization and Challenge
Mice (8–10 weeks old) were injected i.p and s.c. with 0.1 ml of cock-
roach allergen (CRAg, 20,000 protein nitrogen units/ml) emulsifi ed 1:1 
in Incomplete Freund’s adjuvant (Sigma) on day 0. In the standard 
challenge model, mice received an intranasal challenge with 15 µl of 
undiluted CRAg on day 14, followed by intratracheal injections of 40 µl 
CRAg on days 21 and 23. In the chronic challenge model, mice received 
intranasal challenges on days 14, 18, 22, 26 and 30, followed by intratra-
cheal challenges on days 34 and 38. In both models, mice were tested for 
methacholine-elicited airway hyperreactivity (see description below) at 
16–20 hours after the fi nal i.t. challenge, unless otherwise indicated, then 
immediately sacrifi ced for immunological and histological analysis.
Serum IgE Detection
Blood was obtained by retro-orbital eye bleed of anesthetized mice at the 
time of sacrifi ce and allowed to clot at 4 ºC for 1hr prior to removal of 
serum. ELISA plates were coated with polyclonal anti-Ig (BD Pharmin-
gen), washed and incubated with serum for 1 hr. Monoclonal anti-IgE-
biotin conjugated antibody and streptavidin-horseradish peroxidase 
were used for detection of serum IgE. Data represent the combined 
results of six experiments. 
 
Measurement of Lung Cytokine Levels by ELISA
The left lobe was removed from chronically challenged CBA/J and Xid 
mice 16–20 hours after the fi nal i.t. challenge and snap frozen. Lung tissue 
was homogenized in 1 ml PBS buffer containing Triton X-100 and protease 
inhibitors, and debris removed by high speed centrifugation. Samples were 
loaded onto ELISA plates precoated with anti-murine cytokine/chemokine 
antibodies (R&D Systems, Minneapolis, MN). Sandwich ELISA was per-
formed following manufacturer’s instructions and recombinant cytokines 
were used to generate a standard curve for each assay. Data are from a 
representative experiment of three performed.
Real-time PCR for Cytokine Expression in Cultured LN Cells
Mediastinal lymph nodes were removed from chronically challenged 
CBA/J and Xid mice at 16–20 hours post-i.t. challenge. Cells were 
dispersed through a mesh screen, counted and plated in triplicate 
(5x106 cells/ml) in the presence or absence of 200 PNU/ml of CRAg. 
Cells were harvested 16 hrs after initiation of culture, placed in Trizol 
reagent (Invitrogen, Carlsbad, CA), and snap frozen. Total RNA was 
purifi ed following manufacturers instructions and mRNA was reverse 
transcribed using oligo-dT and MMLV-RT from Invitrogen. Real-time 
PCR was performed using an ABI Prism 7700 Sequence Detector and 
reagents from PE Biosystems (San Diego, CA). Individual samples were 
normalized to an internal GAPDH amplifi cation control, then mRNA 
expression was compared between media control and CRAg-stimulated 
samples for each lymph node cell population. Data are expressed as the 
mean fold increase in mRNA expression ± standard error for the tripli-
cate samples of a representative experiment of the three performed. 
Histological Analysis of Peribronchiolar Eosinophilia
Right lung lobes were removed from chronically challenged CBA/J and 
Xid mice 16–20 hrs after the fi nal i.t. challenge and infl ated with 10 % 
neutral buffered formalin. Lungs were embedded in paraffi n, sectioned 
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and stained with either hematoxylin and eosin or periodate acid Schiff 
reagent. Eosinophils were quantifi ed from H&E stained slides by count-
ing infl ammed fi elds adjacent to large airways at 1000X magnifi cation 
for each mouse. Data presented are the number of eosinophils / 20HPF 
for individual mice (n = 5 mice/ strain). Sections from three experiments 
were counted with consistent results.
Measurement of Airway Hyperreactivity
Cockroach allergen immunized mice were anesthetized with pentabar-
bitol in order to paralyze the diaphragm and eliminate background noise 
due to normal breathing activity. Mice were then directly connected to 
a plethysmograph by intratracheal insertion of tubing connected to a 
timed air pump. Expansion of the lungs is measured as the change in air 
pressure in a plexiglass chamber surrounding the mouse compared to the 
amount of air pumped into the lung. A baseline measurement of airway 
resistance is taken (range 1 to 1.5 arbitrary units) prior to intravenous 
tail-vein injection of a 250 µg/kg dose of methacholine. This dosage of 
methacholine induces little to no increase in airway resistance in naïve 
mice. Within 1–2 minutes of methacholine injection, a peak value of air-
way resistance is reached in allergic mice, that returns to baseline within 
5 minutes. The values reported are the ratio of peak / baseline airway 
resistance for each mouse and statistics are based on the number of data 
points shown on the graph. 
Detection of CD95L Expression on Lung Lymphocyte Subsets
Right lobes of mouse lungs were removed at the indicated times post 
i.t. challenge, minced and digested with Type IV collagenase to produce 
single cell suspensions. Cells were fi xed with 1 % paraformaldehyde/
PBS overnight, washed and resuspended in fl ow staining buffer (PBS/
0.2 % BSA/0.1 %NaAzide). One million cells were stained with Fc-
Block followed by staining with anti-mouse CD95L-biotin. After being 
washed, cells were either stained with anti-mouse CD4-PE, CD8-FITC 
and streptavidin-CyChrome, or with anti-mouse CD5-PE, CD19-FITC 
and streptavidin-CyChrome. Analysis of CD95L expression was per-
formed by three-color fl ow cytometry on a Beckman Coulter EPICS 
XL fl ow cytometer (Brea, CA). Data are presented as the ratio of mean 
fl uorescence intensity ± standard error (n = 5 mice/group) of each cell 
population compared to the average staining on the CD4 population at 
24hr post challenge. The data are from one representative experiment of 
the three performed.
Measurement of Lung Th Cell Apoptosis
Lymphocytes were isolated by the method described for CD95L detec-





































Fig. 1. (A): Serum IgE levels remain elevated in Xid mice after chronic 
allergen challenge. Female, 8–10 wk old CBA/J and CBA/HN btk-/- 
<xid>/J (Xid) mice were sensitized by injection with 0.1 ml of CRAg:
IFA emulsion i. p. and s. c. on day 0. Starting at day 14, all mice received 
an intranasal challenge with 15 µl of undiluted CRAg. Mice in the 
‘chronic’ model received an additional four i.n. challenges at four day 
intervals. Two intratracheal challenges of 40 µl were given to the mice in 
both models on the indicated days. Mice were sacrifi ced at time intervals 
ranging from 24 to 72 hrs after the second i. t. challenge as indicated in 
each fi gure. (B): Age matched, naïve and CRAg-sensitized mice were 
anesthetized and eye bled 24 hrs after the second i. t. allergen challenge. 
Serum was prepared and tested for the presence of IgE by sandwich ELI-
SA. Dots represent individual mice in six experiments. Mean serum IgE 
concentrations are shown by the bars and signifi cant differences in Xid 
compared to CBA/J mice in the same model are indicated by asterisk 
(* P < 0.05, *** P < 0.001). The mean serum IgE level was reduced in 
CBA/J mice in the chronic compared to the standard model (P < 0.01).
Figure 2 
Fig. 2. Increased levels of Th2 cytokines and RANTES in the lungs of 
chronically challenged Xid mice. Mice from the chronic model of CRAg-
induced asthma were sacrifi ced 24 hrs after the second i. t. challenge. The 
left lobe of the lung was removed and snap frozen, later homogenized, and 
analyzed for the presence of the indicated cytokines and CCL5 (RANTES) 
by sandwich ELISA. Data were normalized to total protein content in each 
sample. Dots represent cytokine levels from individual mice in a single 
representative experiment of three performed. Means are shown by the bar 
and signifi cance by asterisk (* P < 0.05, ** P < 0.01, *** P < 0.001).
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challenge at the indicated time points after the second i. t. challenge. 
Unfi xed cells (1 × 106) were stained with FcBlock in staining buffer, 
followed by anti-CD4-PE antibodies for 30 min at 4 ºC. Cells were 
then washed with AnnexinV staining buffer (Saline/HEPES/CaCl2) 
and stained with AnnexinV-FITC (Pharmingen) and propidium iodide 
(Sigma) following manufacturer’s instructions. Three-color analysis was 
performed on the EPICS XL fl ow cytometer. Dead cells were removed 
from analysis on the basis of PI+ staining and marker position for AnnV+ 
cells was set using live-gated, lung CD4+ Th cells that were not stained 
with AnnV. Data are the mean percentage of AnnV+ cells within the live 
CD4+ cell population ± standard error, and are the combined results from 
6 experiments with the indicated number of mice / time point. 
Statistical Analysis
Data were plotted and statististically analyzed using the GraphPad Prism 
4.0 (GraphPad Software, San Diego, CA). Where multiple groups or time 
points were present, analysis of variance was performed and signifi cant 
differences were confi rmed by individual Student’s t tests. All other analy-
ses were performed using Student’s t test. Data were considered signifi -
cant when P < 0.05 and were reproducible in replicate experiments.
Results
Lack of serum IgE downregulation in chronically 
challenged Xid mice.
Antigen-reactive IgE contributes to the pathophysiology of 
asthma through binding to Fce receptors on the surface of 
mast cells and basophils. The Xid mutation causes decreased 
levels of B cells, particularly of the B-1a cell subset, and im-
paired antibody responses to some antigens. Therefore, it was 
of interest to measure levels of serum IgE after CRAg chal-
lenge in CBA/J and Xid mice. Using a ‘standard’ induction 
model (Figure 1a) with intraperitoneal and subcutaneous in-
jection of CRAg emulsifi ed in incomplete Freund’s adjuvant, 
followed by a single intranasal challenge and two intratracheal 
challenges, it was found that serum IgE was induced in both 
strains of mice by CRAg treatment, and that Xid mice had an 
elevated amount of serum IgE compared to CBA/J mice (Fig-
ure 1b). To confi rm this result, a more chronic model (Figure 
1a), in which mice received four additional intranasal doses 
of CRAg at four-day intervals was utilized. As shown in Fig-
ure 1b, serum IgE levels were diminished following repeated 
allergen challenge in CBA/J mice but were unchanged in Xid 
mice given repeated CRAg stimulation.
Elevated cytokine levels in lungs of allergen-challenged 
Xid mice.
The increased production of IgE suggested that dysregula-
tion of T cell-derived cytokine production may have oc-
curred. Cytokine protein levels in whole lung homogenates 
were assessed by ELISA 24 hrs after the fi nal CRAg-chal-
lenge. As shown in Figure 2, elevated levels of IL-13, IL-5, 
IL-10 and CCL5 were detected in the lungs of Xid mice after 
repeated allergen challenge. A similar trend was detected 
for IL-4 and IFN-g in the lung, although the increase was 
not statistically signifi cant. In contrast, the levels of eotaxin 
and MIP-1a in the lung were similar in CBA/J and Xid mice 
(data not shown).
Since elevated levels of several cytokines were detected 
in the lungs of Xid mice following repeated allergen chal-
lenge, it was important to determine whether or not the 
difference was due in part to an increased capacity of T 
lymphocytes to produce cytokines in Xid mice. Isolated me-
diastinal lymph node cells from chronically allergen-chal-
lenged CBA/J and Xid mice were cultured in the presence or 
absence of CRAg for 16 hrs. The data in Figure 3 indicated 
signifi cant cytokine mRNA increases for IL-4 and IL-5 in 
CBA/J lymph node cell cultures. A more dramatic increase 
in IL-4 and IL-5 mRNA production was observed in lymph 
node cells from Xid mice in response to CRAg. Addition-
ally, elevated mRNA levels of IL-10 and IFNg were detected 
in the cultures from Xid mice but not from CBA/J mice. IL-
13 mRNA expression was increased equally in both strains 
of mice in the cultures containing CRAg (data not shown). 
Taken together, the cytokine data indicate that B-1a cells 
may play a role in regulating both Th1 and Th2 cells during 
chronic allergen challenge.
Allergen-challenged Xid mice have increased airway 
infl ammation.
Airway infl ammation, mucus hypersecretion and peribron-
chial eosinophilia are hallmarks of the Th2 cytokine-mediated 
infl ammation observed in asthma. As shown in Figure 4 (up-
per panels) an overall increase in pulmonary infl ammation was 
observed in Xid mice compared to CBA/J mice after chronic 
Figure 3 
Fig. 3. Increased cytokine mRNA expression in antigen-stimulated 
lymph node cells from Xid mice. Mediastinal lymph nodes were har-
vested from mice treated with the chronic model 24 hrs after the second 
i. t. challenge. Single cell suspensions were prepared and cultured in the 
presence or absence of CRAg for an additional 16 hrs. Purifi ed RNA was 
reverse transcribed and analyzed for cytokine expression by real-time 
PCR. Data for each sample were normalized to GAPDH expression 
within the sample to control for differences in cell number. Bars indicate 
the fold increase in cytokine mRNA expression following CRAg stimu-
lation compared to the average media control value for that strain. Error 
bars indicate the standard error of replicate samples (n = 4/group) and 
results were reproducible in three experiments. 
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was measured on lung lymphocyte populations. Control CBA/
J mice were treated with the standard induction protocol. As 
shown in Figure 5a, CD95L expression on pulmonary CD5+ 
B-1a cells was elevated at 24 hrs post i. t. challenge compared 
to other lung lymphocyte cell types. At 48 hrs post-challenge, 
CD95L expression was 2–3 fold higher on B-1a cells than on 
other lymphocyte cell types in the lung. Less dramatic, yet 
statistically signifi cant increases in CD95L expression were 
observed on the CD4+ T and CD5– B cell subsets but not on the 
CD8+ T cell subset at 48 hrs post CRAg challenge. 
Impaired CD4+ T cell apoptosis in allergen-challenged 
Xid mice.
To determine the relative contribution of B-1a cells to CD4+ 
T cell apoptosis in the CRAg model, lung lymphocytes from 
allergen sensitized and challenged Xid mice and CBA/J mice 
were harvested and stained for CD4 and the early apoptosis 
marker, Annexin V (Figure 5b). Lung CD4+ T cell apoptosis 
increased two-fold from 24 to 48 hrs post-allergen challenge 
CRAg challenge. Increased infl ammation was accompanied by 
a higher frequency of periodate acid Schiff-staining, mucus-
secreting airway epithelial cells in Xid mice (Figure 4 middle 
panels). Within the infl ammatory lesions, a two-fold increase 
in the number of eosinophils was observed in Xid mice com-
pared to CBA/J mice (Figure 4-E). Despite the alterations 
seen in systemic IgE, lung cytokines and eosinophilia, airway 
hyperreactivity in response to methacholine challenge was not 
signifi cantly increased in Xid mice (Figure 4-F & G).
Fas ligand expression is induced on lung CD5+ B cells 
following allergen challenge.
Upregulation of CD95L expression on splenic B cells, particu-
larly those of the B-1a subset, has been previously observed 
during Th2-type granulomatous response. These CD95L-bear-
ing B-1a cells were shown to regulate CD4+ T cell apoptosis 
and granuloma formation. To determine whether B-1a cell-me-
diated apoptosis of CD4+ T cells was a plausible mechanism 
of regulation in the CRAg model, surface CD95L expression 
Fig. 4. Lung infl ammation is 
increased in Xid mice without 
an increase in airway hyper-
reactivity. Lungs were removed 
24 hrs after the second i. t. 
challenge from chronically sen-
sitized CBA/J (A&C) and Xid 
(B&D) mice, paraffi n embed-
ded, sectioned and stained with 
hematoxylin and eosin (A&B) 
or with periodate acid Schiff 
reagent (C&D). Insets show ar-
eas of leukocytic infl ammation 
surrounding airways in the H&E 
sections with higher numbers of 
eosinophils in the Xid sample 
(B). Mucus secretion is detect-
able by the red staining in the 
PAS stained sections. (E) Eosi-
nophils were counted within ar-
eas of airway infl ammation and 
plotted as the mean ± standard 
error (20 high powered fi elds/
mouse, 5 mice/group). (F&G) 
Airway hyperreactivity was 
measured on anesthetized mice 
and is plotted as the increase 
in airway constriction follow-
ing methacholine challenge 
compared to baseline levels. 
Each dot indicates an individual 
mouse from a representative ex-
periment of three performed.
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in CBA/J mice. No increase in lung CD4+ T cell apoptosis 
was observed in Xid mice during the same time period. The 
percentage of lung T cells undergoing apoptosis in age-
matched, allergen-naïve, CBA/J and Xid mice was 10.0 ± 
2.1 and 5.8 ± 0.5, respectively.
Discussion
The current study supports the hypothesis that CD5+/CD19+ 
B-1a cells play a regulatory role in the CRAg murine model 
of asthma. There was a signifi cant increase in serum IgE in 
B-1a cell defi cient, Xid mice compared to CBA/J control 
mice indicating: 1) that the Xid mutation did not impair 
the ability of B cells to produce IgE antibody in response 
to CRAg sensitization, and 2) that a mechanism which nor-
mally controls IgE production or clearance was absent from 
Xid mice. Previous studies of immune response in Xid mice 
have shown that approximately 2/3 of the total B cells are 
absent from Xid mice. [29] Serum IgM and IgG3 titers were 
severely reduced in naïve New Zealand Black mice carrying 
the xid defect, while serum IgG1, IgG2b and IgA titers were 
similar to controls. [30] Antibody responses to thymus-inde-
pendent antigens were severely compromised in Xid mice 
and response to T-dependent antigens were altered with a 
general reduction in antigen-specifi c IgM, IgG2a and IgG3. 
[31–34] However, the observed increase in IgE in this study 
is consistent with previous fi ndings in parasite infection 
models in which Balb.Xid mice produced greater amounts of 
antigen-specifi c IgE than control Balb/c mice. [35, 36] 
Levels of several Th2 cytokines were elevated in the 
lungs of Xid mice compared to control mice following 
chronic sensitization, suggesting that regulation of pulmo-
nary cytokine levels during chronic asthmatic infl ammation 
may be a normal function of B-1a cells. CRAg stimulation 
of mediastinal lymph node cells from Xid mice resulted in 
increased mRNA expression of IL-4, IL-5, IL-10 and IFN-g. 
The increased level of IL-4 during the chronic infl ammatory 
response may have been responsible for the sustained high 
level of serum IgE observed after repeated allergen chal-
lenge. Another possible explanation of the increased pres-
ence of serum IgE following cockroach allergen challenge is 
an impairment in mast cell uptake. Bruton’s tyrosine kinase 
is critically involved in signal transduction following Fce 
receptor ligation. [37–39] However, no previous reports of 
decreased numbers of mast cells or impairment in IgE uptake 
have been reported in Xid mice. 
The increase in CRAg-induced IFN-g from Xid me-
diastinal lymph node cells was noteworthy, since IFN-g 
production was not induced in LN cells from control mice. 
This fi nding suggested that antigen-reactive, Th1-type cells 
were allowed to persist in Xid mice, and correlated well with 
fi ndings from other groups. Splenocytes from schistosome-
infected Balb.Xid mice produced more IFN-g and IL-4 fol-
lowing specifi c antigenic challenge in vitro. [36] Balb.Xid 
mice were also able to resist infection with Leishmania ma-
jor and produced signifi cantly elevated levels of IFN-g from 
lymph node cells following leishmanial antigen stimulation 
compared to Balb/c control mice. [40] Similarly, resistance 
to Chagas’ disease was reported in Balb.Xid mice along with 
elevated levels of splenic IL-2, IL-4 and IFN-g during early 
stages of infection, and increased susceptibility following 
anti-IFN-g treatment of Balb.Xid mice. [41] In each of the 
above studies, a decreased level of IL-10 was detected from 
the antigen-stimulated cells, suggesting that the lack of regu-
lation of other cytokines was due to the decreased levels of 
IL-10 in Xid mice. Peritoneal B-1a cells have been shown 
to produce IL-10 in response to carbohydrate antigens in the 
schistosome model. [26] However, in the current study, IL-
10 levels were elevated in the lungs of mice receiving chron-
ic CRAg challenges and IL-10 expression was increased in 
the mediastinal lymph node cultures from Xid mice, arguing 
Figure 5 



























































Fig. 5. Cell surface CD95L expression is increased on lung B-1a cells 
after allergen challenge and Xid mice have impaired CD4+ T cell apopto-
sis. (A) Cells were collagenase dispersed from the lungs of CBA/J mice 
treated with the standard model at the indicated times after the second i. t. 
challenge. Paraformaldehyde fi xed cells were stained with CD95L-biotin 
followed by cell surface marker staining and streptavidin-CyChrome. 
Three-color fl ow cytometric analysis was performed to determine sur-
face CD95L expression on the indicated cell populations. A ratio of mean 
fl uorescence intensity (MFI) values was determined by comparison to the 
average staining on the CD4+ cell population at the 24 hr time point. Data 
are the mean ± standard error for 5 mice/group. (*) Signifi cance com-
pared to the CD4+ group at the same time point, (§) signifi cance com-
pared to 24 hr time point within the same cell population. (B) Cells were 
dispersed from lungs of CBA/J and Xid mice at the indicated time points 
after the second i. t. challenge in mice treated with the standard model 
of CRAg-induced asthma. Unfi xed cells were stained with CD4-PE 
followed by staining with Annexin-V-FITC and propidium iodide. Live 
gated Th (CD4+/PI–) cells were analyzed for apoptosis by Annexin-V 
staining. Data are the mean percent apoptotic cells ± standard error com-
piled from six experiments, number in parentheses indicates total number 
of mice per condition. Apoptosis in unimmunized CBA/J and Xid mice 
was 10.0 ± 2.1 and 5.8 ± 0.5 % respectively (n = 5 mice/group).
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against a role for IL-10-mediated down regulation of local 
cytokine production. Yet, it remains possible that B-1a cell-
derived IL-10, that is normally present at the cell-cell inter-
face during cognate B:T cell interactions, plays a regulatory 
role on allergen-sensitized T cells. 
Increased lung infl ammation, peribronchial eosinophilia 
and mucus production by airway epithelial cells were ob-
served in Xid mice following chronic allergen challenge. 
Notably, the proinfl ammatory chemokine, CCL5 (RANTES), 
was highly prevalent in the lungs of all CBA.Xid mice 
regardless of antigenic stimulus or sensitization protocol. 
CCL5 has been previously shown to direct recruitment of 
eosinophils to the lungs in asthma models. [42] The other 
eosinophil chemotactic chemokines, CCL11 (Eotaxin) and 
CCL3 (MIP-1a), were not elevated in Xid mice implicating 
CCL5 as a key mediator regulating lung infl ammation in this 
study. 
Despite the increases in serum IgE, lung and lymph node 
cytokine expression, and peribronchial eosinophilia, no sig-
nifi cant increase in airway hyperreactivity was detected in 
Xid mice. This fi nding may relate to a previously established 
defect in mast cell activation in Xid mice. [37–39] However, 
the increased lung infl ammation most likely led to other det-
rimental responses, including increased mucus production 
within the lungs of Xid mice. It remains to be determined 
whether other methods of blocking B-1a cell regulatory 
function would result in exacerbation of both mucus produc-
tion and airway hyperreactivity in the chronic CRAg model. 
In addition to the above-mentioned role of IL-10 in Th 
cell regulation, another plausible mechanism of Th cell 
regulation by B-1a cells is induction of apoptosis medi-
ated by CD95L. The intensity of surface CD95L expres-
sion was higher on the lung B-1a cell subset isolated from 
allergen-challenged mice than on the lung CD5–/CD19+ 
B cell subset or the CD4+ or CD8+ T cell subsets. Further, 
CD95L expression increased on the B-1a cell subset from 24 
to 48 hrs post-allergen challenge to a greater extent than the 
increase observed on CD4+ T cells or CD5–/CD19+ B cells. 
These fi ndings correlated with a recent study in the schisto-
some granuloma model in which CD95L was constitutively 
present on splenic B-1a cells, was upregulated by infection 
and by in vitro antigen challenge, and in which the B-1a cells 
were demonstrated to be potent effector cells mediating Th 
cell apoptosis. [22] Lung CD4+ T cells in wild-type CBA/J 
mice reacted with an increase in apoptosis 36 hours after 
airway allergen challenge. The apoptotic response peaked at 
48 hours post challenge but remained elevated at 72 hours. In 
contrast, lung CD4+ T cells in CRAg- challenged Xid mice 
did not display an increase in apoptosis at any time point 
tested. The Xid mutation results in a systemic loss of B-1a 
cells, but only a partial loss of function by follicular B cells. 
[43, 44] Thus, the decline in Th cell apoptosis in Xid mice 
implicates the B-1a cell subset as an important effector of 
pulmonary Th cell death during CRAg-induced asthma. This 
is the fi rst report of defective T helper cell apoptosis in B-1a 
cell defi cient Xid mice.
Since the initial report of mitogen-inducible CD95L 
expression on murine B cells, several lines of evidence have 
supported a functional role of ‘regulatory’ B cells in vivo. 
[45] Studies of experimental autoimmune encephalomyelitis 
(EAE), infl ammatory bowel disease and schistosome infec-
tion in B cell defi cient mice have resulted in impairment of 
T cell regulation and increased disease severity. [21, 46–48] 
Further, transfer of LPS-stimulated, CD95L-bearing, puri-
fi ed B cells into NOD mice resulted in inhibition of spon-
taneous diabetes incidence. [49] Transfer of purifi ed B cells 
from male mice into female recipients resulted in CD95L-
dependent tolerance to subsequent male-female skin grafts 
in a transplantation model. [50] The current study further 
supports the regulatory function of B cells, particularly the 
B-1a cell subset, during chronic infl ammation.
The presence of a regulatory function of B cells has been 
established in several clinically relevant mouse models, 
including the CRAg-induced asthma model. Further, sev-
eral correlations have been drawn between the expression 
of CD95L on human B cell lymphomas and autoreactive 
B cells and escape from immune surveillance. [51–53] It 
remains to be determined whether alterations in regulatory 
B cell function result in increased T cell activity and exac-
erbated disease severity in asthmatic patients. The current 
study suggests that differences in antibody production, lung 
infl ammation, lung cytokine levels, or Th cell apoptosis may 
be markers of impaired B-1a cell regulatory function.
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